Underutilization of warfarin in older persons with chronic nonvalvular atrial fibrillation at high risk for developing stroke

Journal of the American Geriatrics Society

Volumn 46, Issue 11, 1998, Pages 1423-1424

  Mendelson, Gad ^a   Aronow, Wilbert S ^a,b  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b HEBREW HOSPITAL HOME   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; WARFARIN;

ADULT; AGED; ANTICOAGULANT THERAPY; ARTICLE; DRUG CHOICE; FEMALE; HEART ATRIUM FIBRILLATION; HEART LEFT VENTRICLE FUNCTION; HUMAN; MAJOR CLINICAL STUDY; MALE; STROKE; THROMBOEMBOLISM; TREATMENT PLANNING;

EID: 0031789234     PISSN: 00028614     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1532-5415.1998.tb06011.x     Document Type: Article

References (3)

1. Wolf PA, Abbott RD, Kannel WB. Atrial fibrillation as an independent risk factor for stroke: The Framingham Study. Stroke 1991;22:983-988.
2. Aronow WS, Ahn C, Gutstein H. Prevalence of atrial fibrillation and association of atrial fibrillation with prior and new thromboembolic stroke in older patients. J Am Geriatr Soc 1996;44:521-523.
3. Stroke Prevention in Atrial Fibrillation Investigators. Adjusted-dose warfarin versus low-intensity, fixed-dose warfarin plus aspirin for high-risk patients with atrial fibrillation: Stroke Prevention in Atrial Fibrillation III randomised clinical trial. Lancet 1996;348:633-638.